Minimally invasive lumbar spinal fusion cage gets FDA nod

Zavation Medical’s EZspand lateral cage received FDA clearance.

Advertisement

The device is part of Zavation’s EZspand interbody portfolio, according to a June 10 news release. The lateral cage does not require secondary locking, cutting down on extra procedural steps. It has up to 15 degrees lordosis and the ability to back fill with bone graft.

“With restoration of alignment being of critical importance, the EZspand Lateral was developed to help surgeons address stability and sagittal alignment while maximizing lordotic correction,” Zavation CEO Jeffrey Johnson said in the release.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.